Literature DB >> 11157110

Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.

M Kamali1, L Kelly, M Gervin, S Browne, C Larkin, E O'Callaghan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11157110     DOI： 10.1176/appi.ps.52.2.161

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN： 1075-2730            Impact factor:   3.084


× No keyword cloud information.
  9 in total

Review 1.  Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.

Authors:  P T Yanos; R H Moos
Journal:  Clin Psychol Rev       Date:  2006-02-09

Review 2.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

3.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Joseph Ventura; Michael J Gitlin; Stephen Marder; Jim Mintz; Gerhard S Hellemann; Leslie A Thornton; Indira R Singh
Journal:  Am J Psychiatry       Date:  2011-01-04       Impact factor: 18.112

4.  Schizophrenia in general practice: a national survey of general practitioners in Ireland.

Authors:  B Gavin; W Cullen; B O'Donoghue; J C Ascencio-Lane; G Bury; E O'Callaghan
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

Review 5.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

6.  Compliance therapy: a randomised controlled trial in schizophrenia.

Authors:  Colin O'Donnell; Gary Donohoe; Louise Sharkey; Nicholas Owens; Maria Migone; Raewynn Harries; Anthony Kinsella; Conall Larkin; Eadbhard O'Callaghan
Journal:  BMJ       Date:  2003-10-11

Review 7.  Are attitudes towards medication adherence associated with medication adherence behaviours among patients with psychosis? A systematic review and meta analysis.

Authors:  Michelle Richardson; Rose McCabe; Stefan Priebe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-09       Impact factor: 4.328

8.  Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.

Authors:  Gunnar Morken; Jan H Widen; Rolf W Grawe
Journal:  BMC Psychiatry       Date:  2008-04-30       Impact factor: 3.630

9.  Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis.

Authors:  Carsten Hjorthøj; Allan Fohlmann; Anne-Mette Larsen; Mette T R Madsen; Lone Vesterager; Christian Gluud; Mikkel C Arendt; Merete Nordentoft
Journal:  Trials       Date:  2008-07-11       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.